— Know what they know.
Not Investment Advice
Also trades as: ROVI.MC (BME) · $vol 7M · 0ILL.L (LSE) · $vol 1M

LABFF OTC

Laboratorios Farmaceuticos Rovi, S.A.
1W: +0.0% 1M: +0.0% 3M: -25.0% YTD: -25.9% 1Y: -25.9% 3Y: +34.9% 5Y: +4.7%
$67.17
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 44 · $3.4B mcap · 16M float · 0.0005% daily turnover · Short 100% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 2Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 02, 2026
DCF
4
ROE
5
ROA
5
D/E
2
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. LABFF receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (2/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-03 None ADDED
2026-10-03 EXISTED None
2026-09-29 None ADDED
2026-09-27 EXISTED None
2026-09-23 None ADDED
2026-09-23 EXISTED None
2026-09-19 None ADDED
2026-09-19 EXISTED None
2026-09-15 None ADDED
2026-09-13 EXISTED None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
88
Balance Sheet
86
Earnings Quality
66
Growth
61
Value
—
Momentum
87
Safety
—
Cash Flow
87

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
6/9
✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✗
Beneish M-Score
-2.72
Unlikely Manipulator
Ohlson O-Score
-9.55
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 82.8/100
Trend: Stable
Earnings Quality
75/100
OCF/NI: 1.36x
Accruals: -6.8%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LABFF scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. LABFF's score of -2.72 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LABFF's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LABFF receives an estimated rating of AA- (score: 82.8/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). LABFF's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
15.86x
PEG
-2.37x
P/S
3.80x
P/B
4.19x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$33.41
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 15.9x earnings, LABFF trades at a reasonable valuation. Graham's intrinsic value formula yields $33.41 per share, 101% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.787
NI / EBT
×
Interest Burden
0.982
EBT / EBIT
×
EBIT Margin
0.310
EBIT / Rev
×
Asset Turnover
0.775
Rev / Assets
×
Equity Multiplier
1.579
Assets / Equity
=
ROE
29.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LABFF's ROE of 29.3% is driven by Asset Turnover (0.775), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
1.34%
Fair P/E
11.17x
Intrinsic Value
$40.46
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with LABFF's realized 1.3% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. LABFF trades at a premium to its adjusted intrinsic value of $40.46, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 11.2x compares to the current market P/E of 15.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1327 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$67.17
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$2.85
Ann. Volatility
469.3%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 16.6% 27.4% 42.8% 45.5% 39.3% 40.3% 39.1% 40.6% 39.7% 32.2% 25.4% 29.8% 30.0% 24.6% 25.2% 25.4% 20.7% 22.7% 20.8% 29.3% 29.30%
ROA 11.0% 17.6% 24.5% 25.4% 24.1% 24.8% 23.8% 22.0% 24.6% 20.3% 16.6% 16.8% 19.3% 16.8% 17.6% 15.3% 13.5% 15.7% 15.1% 18.6% 18.55%
ROIC 19.5% 28.8% 45.7% 57.9% 41.8% 42.4% 38.8% 43.1% 35.0% 29.4% 23.5% 26.9% 25.2% 21.0% 25.2% 20.8% 21.5% 19.6% 18.6% 19.6% 19.65%
ROCE 17.7% 27.8% 44.1% 46.7% 41.4% 43.3% 39.0% 40.6% 41.2% 36.6% 30.3% 32.6% 32.4% 26.5% 26.5% 25.3% 21.6% 23.9% 22.5% 28.2% 28.16%
Gross Margin 64.6% 61.6% 60.7% 58.1% 59.9% 69.9% 62.5% 51.0% 63.7% 55.2% 56.7% 61.9% 69.4% 54.4% 58.4% 65.9% 70.2% 59.9% 55.6% 68.7% 68.68%
Operating Margin 34.6% 31.4% 33.4% 20.4% 26.9% 40.9% 30.1% 13.7% 31.9% 28.5% 12.8% 20.9% 38.3% 16.5% 14.9% 17.5% 36.3% 25.1% 6.5% 15.0% 14.97%
Net Margin 27.6% 29.2% 25.8% 15.8% 21.0% 32.3% 23.5% 10.7% 24.4% 22.0% 9.9% 16.5% 29.4% 11.7% 11.7% 13.5% 27.6% 19.5% 6.2% 39.1% 39.13%
EBITDA Margin 38.3% 31.4% 35.8% 22.1% 30.7% 40.8% 32.9% 15.5% 35.9% 28.5% 17.0% 22.8% 42.8% 16.4% 19.5% 19.5% 39.9% 30.6% 13.9% 52.7% 52.73%
FCF Margin 28.6% 16.9% 26.2% 26.0% 18.9% 22.8% 12.8% 7.5% 7.2% 7.0% 5.8% 4.5% 8.0% 10.0% 10.4% 9.6% 14.9% 16.2% 15.5% 22.9% 22.85%
OCF Margin 34.0% 24.1% 31.6% 31.3% 23.9% 29.1% 19.4% 14.8% 14.3% 13.7% 13.4% 11.6% 15.8% 18.1% 18.4% 18.2% 24.1% 25.1% 24.4% 32.7% 32.67%
ROE 3Y Avg snapshot only 27.00%
ROE 5Y Avg snapshot only 32.54%
ROA 3Y Avg snapshot only 16.30%
ROIC 3Y Avg snapshot only 21.91%
ROIC Economic snapshot only 16.86%
Cash ROA snapshot only 22.42%
Cash ROIC snapshot only 37.16%
CROIC snapshot only 25.99%
NOPAT Margin snapshot only 17.27%
Pretax Margin snapshot only 30.41%
R&D / Revenue snapshot only 6.00%
SGA / Revenue snapshot only 26.91%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 15.856
P/S Ratio — — — — — — — — — — — — — — — — — — — — 3.797
P/B Ratio — — — — — — — — — — — — — — — — — — — — 4.191
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
Graham Number snapshot only $33.41
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.99 2.66 2.10 1.77 2.10 2.12 2.47 1.98 2.57 2.55 2.54 1.98 2.50 3.13 3.70 2.77 3.02 3.14 3.66 2.05 2.054
Quick Ratio 1.60 1.37 1.10 0.94 0.97 1.06 1.19 0.89 0.91 0.86 0.77 0.68 0.94 1.02 1.18 1.01 1.32 1.55 1.80 1.07 1.067
Debt/Equity 0.16 0.16 0.17 0.18 0.17 0.14 0.12 0.13 0.12 0.12 0.16 0.25 0.23 0.20 0.00 0.23 0.00 0.22 0.17 0.15 0.153
Net Debt/Equity -0.16 -0.05 -0.07 -0.21 -0.05 -0.10 -0.13 -0.17 0.01 0.07 0.13 0.16 0.20 0.15 -0.05 0.14 -0.08 0.07 0.03 -0.03 -0.029
Debt/Assets 0.10 0.10 0.10 0.09 0.10 0.08 0.08 0.07 0.08 0.08 0.11 0.14 0.15 0.14 0.00 0.15 0.00 0.15 0.12 0.10 0.095
Debt/EBITDA 0.69 0.45 0.31 0.31 0.32 0.27 0.26 0.26 0.24 0.27 0.41 0.58 0.55 0.57 0.00 0.66 0.00 0.69 0.57 0.39 0.394
Net Debt/EBITDA -0.69 -0.16 -0.12 -0.36 -0.10 -0.19 -0.27 -0.35 0.03 0.17 0.35 0.36 0.47 0.44 -0.14 0.42 -0.28 0.23 0.08 -0.08 -0.075
Interest Coverage 217.00 228.12 253.25 250.28 243.63 299.17 310.78 299.73 309.47 96.98 73.24 75.05 64.89 52.56 49.14 42.28 41.15 65.14 58.51 56.02 56.016
Equity Multiplier 1.51 1.56 1.75 1.98 1.75 1.69 1.56 1.74 1.51 1.48 1.50 1.80 1.60 1.45 1.38 1.54 1.48 1.44 1.37 1.61 1.609
Cash Ratio snapshot only 0.463
Debt Service Coverage snapshot only 63.881
Cash to Debt snapshot only 1.191
FCF to Debt snapshot only 1.644
Defensive Interval snapshot only 323.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.49 0.71 0.97 1.03 1.04 1.01 1.00 0.97 1.04 0.99 0.94 0.89 0.94 0.94 0.96 0.87 0.80 0.83 0.85 0.77 0.775
Inventory Turnover 0.62 0.85 1.17 1.24 1.18 1.10 1.04 1.02 0.96 1.07 1.01 0.89 0.87 0.89 0.90 0.82 0.82 0.87 0.92 0.93 0.927
Receivables Turnover 3.04 3.99 4.28 6.76 5.86 5.64 4.94 7.08 5.80 5.83 5.34 6.75 4.94 6.01 6.20 5.83 3.84 5.08 5.28 5.45 5.448
Payables Turnover 1.35 2.09 2.17 3.39 2.67 2.71 2.23 3.06 2.62 2.97 2.78 3.35 2.61 3.04 2.99 3.87 2.40 3.47 3.27 3.75 3.748
DSO 120 91 85 54 62 65 74 52 63 63 68 54 74 61 59 63 95 72 69 67 67.0 days
DIO 588 431 312 295 308 333 349 358 382 343 361 408 419 412 407 443 443 419 398 394 393.7 days
DPO 270 174 168 108 137 135 163 119 139 123 131 109 140 120 122 94 152 105 112 97 97.4 days
Cash Conversion Cycle 438 348 229 241 234 263 260 290 306 282 298 353 353 353 343 411 387 386 355 363 363.3 days
Fixed Asset Turnover snapshot only 1.593
Operating Cycle snapshot only 460.7 days
Cash Velocity snapshot only 6.040
Capital Intensity snapshot only 1.457
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — 3.6% 1.3% 57.8% 12.4% 10.7% 10.0% 1.4% -4.3% -4.9% -4.5% -7.9% -1.5% -3.7% -9.4% -2.7% -3.4% 3.3% 3.28%
Net Income — — — 5.7% 1.3% 54.5% 6.5% 1.7% 12.2% -14.7% -29.0% -20.3% -16.2% -19.6% 1.6% -10.6% -26.6% 2.6% -5.8% 40.0% 40.02%
EPS — — — 6.0% 1.5% 58.8% 7.5% 1.7% 7.9% -12.1% -26.1% -20.3% -16.3% -18.5% 1.9% -6.7% -23.4% 2.5% -5.9% 40.0% 40.01%
FCF — — — 2.5% 51.4% 1.1% -45.3% -68.2% -58.3% -68.8% -56.6% -43.0% 6.5% 31.0% 77.9% 1.1% 68.3% 58.1% 43.4% 1.4% 1.45%
EBITDA — — — 5.3% 1.2% 67.1% 11.9% 6.8% 17.2% -12.2% -25.1% -16.9% -13.4% -16.1% 3.3% -7.5% -24.0% 6.2% -0.4% 40.4% 40.42%
Op. Income — — — 5.6% 1.3% 68.6% 12.4% 6.4% 17.4% -13.9% -27.9% -19.1% -15.4% -18.5% 2.5% -9.1% -24.9% 1.5% -7.7% -2.4% -2.40%
OCF Growth snapshot only 85.06%
Asset Growth snapshot only 29.60%
Equity Growth snapshot only 24.30%
Debt Growth snapshot only -16.84%
Shares Change snapshot only 0.01%
Dividend Growth snapshot only -1.00%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — 69.6% 33.9% 13.8% 2.0% 0.4% -1.6% -3.1% -3.0% -1.9% -1.85%
Revenue 5Y — — — — — — — — — — — — — — — — — — — 37.1% 37.13%
EPS 3Y — — — — — — — — — — — 78.1% 31.6% 4.4% -6.8% -8.9% -11.5% -9.8% -10.8% 1.3% 1.34%
EPS 5Y — — — — — — — — — — — — — — — — — — — 49.1% 49.14%
Net Income 3Y — — — — — — — — — — — 75.9% 30.0% 1.9% -8.4% -10.2% -11.6% -11.1% -12.1% -0.1% -0.09%
Net Income 5Y — — — — — — — — — — — — — — — — — — — 46.8% 46.78%
EBITDA 3Y — — — — — — — — — — — 77.7% 31.0% 7.2% -4.7% -6.4% -8.3% -7.9% -8.3% 2.6% 2.60%
EBITDA 5Y — — — — — — — — — — — — — — — — — — — 48.8% 48.77%
Gross Profit 3Y — — — — — — — — — — — 76.5% 35.6% 14.7% 2.8% 1.1% -0.4% -2.6% -3.0% -0.6% -0.56%
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — 42.6% 42.61%
Op. Income 3Y — — — — — — — — — — — 78.6% 31.6% 5.8% -6.0% -7.9% -9.3% -10.7% -12.0% -10.5% -10.47%
Op. Income 5Y — — — — — — — — — — — — — — — — — — — 38.2% 38.25%
FCF 3Y — — — — — — — — — — — -14.2% -12.4% -4.6% -25.0% -27.8% -9.3% -13.6% 3.4% 42.5% 42.54%
FCF 5Y — — — — — — — — — — — — — — — — — — — 26.2% 26.24%
OCF 3Y — — — — — — — — — — — 13.0% 3.7% 3.5% -14.8% -16.1% -1.3% -7.7% 4.6% 27.9% 27.93%
OCF 5Y — — — — — — — — — — — — — — — — — — — 32.2% 32.17%
Assets 3Y — — — — — — — — — — — 10.0% 8.6% 4.3% 3.0% 3.2% 6.1% 2.8% 1.7% 7.8% 7.79%
Assets 5Y — — — — — — — — — — — — — — — — — — — 11.8% 11.83%
Equity 3Y — — — — — — — — — — — 5.6% 6.6% 6.7% 11.5% 12.2% 12.1% 8.5% 6.0% 10.7% 10.69%
Book Value 3Y — — — — — — — — — — — 7.0% 7.9% 9.2% 13.5% 13.8% 12.2% 10.0% 7.6% 12.3% 12.27%
Dividend 3Y — — — — — — — — — — — 12.0% -5.3% -4.3% -4.8% -5.2% — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — — 0.84 0.86 0.78 0.37 0.64 0.66 0.44 0.11 0.00 0.15 0.80 0.97 0.60 0.597
Earnings Stability — — — — — — — 0.76 0.88 0.34 0.56 0.40 0.49 0.00 0.67 0.19 0.07 0.05 0.73 0.28 0.276
Margin Stability — — — — — — — 0.91 0.97 0.96 0.95 0.93 0.97 0.97 0.96 0.98 0.98 0.96 0.95 0.93 0.926
Rev. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.50 0.00 0.50 0.500
FCF Positive Streak 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence — — — — — — — 0.99 0.95 0.94 0.88 0.92 0.94 0.92 0.99 0.96 0.89 0.99 0.98 0.84 0.840
Earnings Smoothness — — — 0.00 0.20 0.57 0.94 0.98 0.89 0.84 0.66 0.77 0.82 0.78 0.98 0.89 0.69 0.97 0.94 0.67 0.667
ROE Trend — — — — — — — 0.10 0.08 -0.01 -0.12 -0.10 -0.08 -0.11 -0.07 -0.10 -0.13 -0.07 -0.06 -0.01 -0.008
Gross Margin Trend — — — — — — — 0.05 0.03 -0.03 -0.05 -0.02 -0.00 0.01 0.02 0.02 0.01 0.04 0.04 0.03 0.031
FCF Margin Trend — — — — — — — -0.23 -0.17 -0.13 -0.14 -0.12 -0.05 -0.05 0.01 0.04 0.07 0.08 0.07 0.16 0.158
Sustainable Growth Rate 11.9% 22.9% 37.8% 40.1% 27.8% 30.0% 28.8% 29.4% 25.8% 19.1% 12.7% 15.9% 19.7% 14.5% 15.1% 14.6% 20.7% 22.7% 20.8% 29.3% 29.30%
Internal Growth Rate 8.5% 17.2% 27.5% 28.9% 20.6% 22.6% 21.3% 18.9% 19.0% 13.7% 9.0% 9.9% 14.6% 10.9% 11.7% 9.6% 15.6% 18.6% 17.8% 22.8% 22.78%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.51 0.97 1.26 1.27 1.03 1.19 0.81 0.65 0.61 0.66 0.76 0.61 0.76 1.01 1.01 1.03 1.44 1.33 1.37 1.36 1.364
FCF/OCF 0.84 0.70 0.83 0.83 0.79 0.78 0.66 0.51 0.50 0.51 0.43 0.38 0.51 0.55 0.57 0.53 0.62 0.64 0.64 0.70 0.700
FCF/Net Income snapshot only 0.954
OCF/EBITDA snapshot only 0.925
CapEx/Revenue 5.4% 7.2% 5.4% 5.3% 4.9% 6.3% 6.7% 7.3% 7.1% 6.7% 7.6% 7.2% 7.8% 8.1% 8.0% 8.6% 9.2% 8.9% 8.9% 9.8% 9.82%
CapEx/Depreciation snapshot only 2.258
Accruals Ratio -0.06 0.01 -0.06 -0.07 -0.01 -0.05 0.04 0.08 0.10 0.07 0.04 0.07 0.05 -0.00 -0.00 -0.00 -0.06 -0.05 -0.06 -0.07 -0.068
Sloan Accruals snapshot only -0.072
Cash Flow Adequacy snapshot only 3.328
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 1.35%
Dividend/Share $0.39 $0.39 $0.40 $0.40 $1.00 $0.96 $0.96 $0.96 $1.29 $1.33 $1.35 $1.29 $1.06 $1.10 $1.10 $1.10 $0.00 $0.00 $0.00 $0.00 $0.78
Payout Ratio 28.5% 16.7% 11.9% 11.8% 29.2% 25.5% 26.3% 27.5% 35.1% 40.5% 50.1% 46.6% 34.2% 41.2% 40.3% 42.7% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 22.5% 24.6% 11.4% 11.3% 35.6% 27.4% 49.1% 83.6% 1.1% 1.2% 1.5% 2.0% 88.3% 74.2% 70.5% 78.2% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 58.8% 66.8% 1.0% 1.1% 1.4% 1.1% 82.1% 80.6% 85.1% 1.2% 1.5% 1.4% 1.2% 1.1% 90.1% 92.6% 52.7% 39.1% 46.8% 35.5% 35.54%
Div. Increase Streak 0 0 0 0 1 1 1 1 1 1 1 1 0 0 0 0 — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.79 0.84 0.82 0.82 0.81 0.77 0.78 0.78 0.78 0.77 0.77 0.78 0.78 0.77 0.77 0.77 0.77 0.77 0.76 0.79 0.787
Interest Burden (EBT/EBIT) 1.02 1.01 1.01 1.02 1.01 1.02 1.02 1.01 1.01 1.00 1.00 1.00 1.00 0.99 0.99 0.99 0.99 0.99 0.98 0.98 0.982
EBIT Margin 0.28 0.29 0.30 0.30 0.28 0.31 0.30 0.29 0.30 0.26 0.23 0.25 0.27 0.23 0.24 0.23 0.22 0.25 0.24 0.31 0.310
Asset Turnover 0.49 0.71 0.97 1.03 1.04 1.01 1.00 0.97 1.04 0.99 0.94 0.89 0.94 0.94 0.96 0.87 0.80 0.83 0.85 0.77 0.775
Equity Multiplier 1.51 1.56 1.75 1.79 1.63 1.63 1.64 1.85 1.61 1.58 1.53 1.77 1.55 1.47 1.44 1.66 1.54 1.45 1.38 1.58 1.579
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $1.36 $2.36 $3.38 $3.42 $3.42 $3.74 $3.64 $3.48 $3.69 $3.29 $2.69 $2.77 $3.09 $2.68 $2.74 $2.59 $2.37 $2.75 $2.58 $3.62 $3.62
Book Value/Share $8.18 $8.59 $7.89 $7.48 $8.61 $9.74 $10.63 $9.68 $10.33 $10.41 $10.13 $8.92 $10.28 $11.19 $11.53 $11.02 $12.16 $12.98 $13.23 $13.70 $14.02
Tangible Book/Share $7.48 $7.88 $7.19 $6.78 $7.90 $9.07 $9.97 $9.04 $9.70 $9.87 $9.48 $8.41 $9.67 $10.52 $10.83 $10.32 $11.46 $12.28 $12.54 $13.00 $13.00
Revenue/Share $6.01 $9.45 $13.42 $13.85 $14.82 $15.32 $15.25 $15.33 $15.68 $16.01 $15.18 $14.57 $14.97 $14.94 $15.01 $14.64 $14.16 $14.53 $14.50 $15.12 $15.11
FCF/Share $1.72 $1.60 $3.52 $3.60 $2.81 $3.49 $1.95 $1.14 $1.13 $1.12 $0.88 $0.65 $1.20 $1.49 $1.57 $1.41 $2.11 $2.35 $2.24 $3.46 $3.46
OCF/Share $2.04 $2.27 $4.25 $4.34 $3.54 $4.45 $2.96 $2.26 $2.24 $2.19 $2.03 $1.69 $2.36 $2.70 $2.77 $2.67 $3.41 $3.65 $3.53 $4.94 $4.94
Cash/Share $2.60 $1.81 $1.89 $2.98 $1.90 $2.34 $2.65 $2.91 $1.06 $0.49 $0.25 $0.85 $0.33 $0.54 $0.57 $0.93 $0.96 $1.91 $1.91 $2.50 $2.50
EBITDA/Share $1.88 $2.96 $4.37 $4.44 $4.49 $5.08 $4.94 $4.74 $5.06 $4.59 $3.85 $3.94 $4.38 $3.90 $3.99 $3.80 $3.48 $4.14 $3.97 $5.34 $5.34
Debt/Share $1.30 $1.33 $1.34 $1.37 $1.43 $1.35 $1.30 $1.25 $1.19 $1.26 $1.59 $2.27 $2.40 $2.24 $0.00 $2.53 $0.00 $2.85 $2.25 $2.10 $2.10
Net Debt/Share $-1.30 $-0.47 $-0.55 $-1.61 $-0.47 $-0.99 $-1.35 $-1.67 $0.14 $0.77 $1.34 $1.42 $2.07 $1.70 $-0.57 $1.60 $-0.96 $0.94 $0.33 $-0.40 $-0.40
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 4 3 4 8 7 8 7 6 7 6 5 4 3 5 7 6 7 5 3 6 6
Beneish M-Score — — — -2.64 -2.20 -2.58 -2.44 -2.21 -2.20 -2.26 -2.45 -1.99 -1.84 -2.13 -2.40 -2.40 -2.51 -2.56 -2.46 -2.72 -2.722
Ohlson O-Score snapshot only -9.547
ROIC (Greenblatt) snapshot only 30.82%
Net-Net WC snapshot only $3.09
EVA snapshot only $65608445.84
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA-
Credit Score 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 76.60 80.95 82.75 78.50 82.75 78.50 82.75 82.75 82.75 82.750
Credit Grade snapshot only 4
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 100.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms